Article Information
History
- February 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Elisabetta Colosi1,
- Giulia Bassignana1,
- Alain Barrat2,3,
- Bruno Lina4,5,
- Philippe Vanhems6,
- Julia Bielicki7 and
- Vittoria Colizza1,3,*
- 1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
- 2Aix Marseille Univ, Université de Toulon, CNRS, CPT, Turing Center for Living Systems, Marseille, France
- 3Tokyo Tech World Research Hub Initiative (WRHI), Tokyo Institute of Technology, Tokyo, Japan
- 4National Reference Center for Respiratory Viruses, Department of Virology, Infective Agents Institute, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France
- 5Virpath Laboratory, International Center of Research in Infectiology, INSERM U1111, CNRS—UMR 5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon, Lyon University, Lyon, France
- 6Service d’Hygiène, Épidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon, Lyon, France
- 7Paediatric Infectious Diseases, University of Basel Children’s Hospital, Spitalstrasse 33, 4056, Basel, Switzerland
- ↵*corresponding author: vittoria.colizza{at}inserm.fr
Posted February 06, 2022.
Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022
